Metabolism and action of amino acid analog anti-cancer agents

Gurpreet S. Ahluwalia, Jean L Grem, Zhang Hao, David A. Cooney

Research output: Contribution to journalReview article

138 Citations (Scopus)

Abstract

The preclinical pharmacology, antitumor activity and toxicity of seven of the more important amino acid analogs, with antineoplastic activity, is discussed in this review. Three of these compounds are antagonists of l-glutamine: acivicin, DON and azaserine; and two are analogs of l-aspartic acid; PALA and l-alanosine. All five of these antimetabolites interrupt cellular nucleotide synthesis and thereby halt the formation of DNA and/or RNA in the tumor cell. The remaining two compounds, buthionine sulfoximine and difluoromethylornithine, are inhibitors of glutathione and polyamine synthesis, respectively, with limited intrinsic antitumor activity; however, because of their powerful biochemical actions and their low systemic toxicities, they are being evaluated as chemotherapeutic adjuncts to or modulators of other more toxic antineoplastic agents.

Original languageEnglish (US)
Pages (from-to)243-271
Number of pages29
JournalPharmacology and Therapeutics
Volume46
Issue number2
DOIs
StatePublished - Jan 1 1990

Fingerprint

alanosine
NSC 224131
acivicin
Antineoplastic Agents
Azaserine
Buthionine Sulfoximine
Eflornithine
Amino Acids
Antimetabolites
Poisons
Polyamines
Glutamine
Aspartic Acid
Glutathione
Neoplasms
Nucleotides
Pharmacology
RNA
DNA

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Metabolism and action of amino acid analog anti-cancer agents. / Ahluwalia, Gurpreet S.; Grem, Jean L; Hao, Zhang; Cooney, David A.

In: Pharmacology and Therapeutics, Vol. 46, No. 2, 01.01.1990, p. 243-271.

Research output: Contribution to journalReview article

Ahluwalia, Gurpreet S. ; Grem, Jean L ; Hao, Zhang ; Cooney, David A. / Metabolism and action of amino acid analog anti-cancer agents. In: Pharmacology and Therapeutics. 1990 ; Vol. 46, No. 2. pp. 243-271.
@article{64a91b1015ae453bac2fea6c468df254,
title = "Metabolism and action of amino acid analog anti-cancer agents",
abstract = "The preclinical pharmacology, antitumor activity and toxicity of seven of the more important amino acid analogs, with antineoplastic activity, is discussed in this review. Three of these compounds are antagonists of l-glutamine: acivicin, DON and azaserine; and two are analogs of l-aspartic acid; PALA and l-alanosine. All five of these antimetabolites interrupt cellular nucleotide synthesis and thereby halt the formation of DNA and/or RNA in the tumor cell. The remaining two compounds, buthionine sulfoximine and difluoromethylornithine, are inhibitors of glutathione and polyamine synthesis, respectively, with limited intrinsic antitumor activity; however, because of their powerful biochemical actions and their low systemic toxicities, they are being evaluated as chemotherapeutic adjuncts to or modulators of other more toxic antineoplastic agents.",
author = "Ahluwalia, {Gurpreet S.} and Grem, {Jean L} and Zhang Hao and Cooney, {David A.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/0163-7258(90)90094-I",
language = "English (US)",
volume = "46",
pages = "243--271",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Metabolism and action of amino acid analog anti-cancer agents

AU - Ahluwalia, Gurpreet S.

AU - Grem, Jean L

AU - Hao, Zhang

AU - Cooney, David A.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The preclinical pharmacology, antitumor activity and toxicity of seven of the more important amino acid analogs, with antineoplastic activity, is discussed in this review. Three of these compounds are antagonists of l-glutamine: acivicin, DON and azaserine; and two are analogs of l-aspartic acid; PALA and l-alanosine. All five of these antimetabolites interrupt cellular nucleotide synthesis and thereby halt the formation of DNA and/or RNA in the tumor cell. The remaining two compounds, buthionine sulfoximine and difluoromethylornithine, are inhibitors of glutathione and polyamine synthesis, respectively, with limited intrinsic antitumor activity; however, because of their powerful biochemical actions and their low systemic toxicities, they are being evaluated as chemotherapeutic adjuncts to or modulators of other more toxic antineoplastic agents.

AB - The preclinical pharmacology, antitumor activity and toxicity of seven of the more important amino acid analogs, with antineoplastic activity, is discussed in this review. Three of these compounds are antagonists of l-glutamine: acivicin, DON and azaserine; and two are analogs of l-aspartic acid; PALA and l-alanosine. All five of these antimetabolites interrupt cellular nucleotide synthesis and thereby halt the formation of DNA and/or RNA in the tumor cell. The remaining two compounds, buthionine sulfoximine and difluoromethylornithine, are inhibitors of glutathione and polyamine synthesis, respectively, with limited intrinsic antitumor activity; however, because of their powerful biochemical actions and their low systemic toxicities, they are being evaluated as chemotherapeutic adjuncts to or modulators of other more toxic antineoplastic agents.

UR - http://www.scopus.com/inward/record.url?scp=0025232412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025232412&partnerID=8YFLogxK

U2 - 10.1016/0163-7258(90)90094-I

DO - 10.1016/0163-7258(90)90094-I

M3 - Review article

VL - 46

SP - 243

EP - 271

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 2

ER -